{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:53:41Z","timestamp":1790146421856,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.soncn.2022.151284","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:07:25Z","timestamp":1652479645000},"page":"151284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?"],"prefix":"10.1016","volume":"38","author":[{"given":"Laura","family":"Elst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soncn.2022.151284_bib0001","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.2011-3865","article-title":"HPV vaccine recommendations","volume":"129","author":"Brady","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0002","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"De Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.soncn.2022.151284_bib0003","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"De Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soncn.2022.151284_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106363","article-title":"Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination","volume":"144","author":"Oliveira","year":"2021","journal-title":"Prev Med"},{"issue":"10197","key":"10.1016\/j.soncn.2022.151284_bib0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.soncn.2022.151284_bib0006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(21)00327-3","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Goldstone","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.soncn.2022.151284_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.soncn.2022.151284_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.soncn.2022.151284_bib0009","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunizations Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MOU.0000000000000730","article-title":"Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article","volume":"30","author":"da Costa Nunes","year":"2020","journal-title":"Curr Opin Urol"},{"issue":"8","key":"10.1016\/j.soncn.2022.151284_bib0011","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","article-title":"Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015","volume":"142","author":"Hansen","year":"2018","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0012","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1203475419888869","article-title":"Penile invasive squamous cell carcinoma: analysis of incidence, mortality trends, and geographic distribution in Canada","volume":"24","author":"Lagac\u00e9","year":"2020","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.soncn.2022.151284_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/iju.13871","article-title":"Penile intraepithelial neoplasia: nomenclature, incidence and progression to malignancy in the Netherlands","volume":"26","author":"Hoekstra","year":"2019","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0014","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-008-0310-z","article-title":"Multimodality therapy in penile cancer: when and which treatments?","volume":"27","author":"Pagliaro","year":"2009","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.soncn.2022.151284_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.soncn.2022.151284_bib0016","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","article-title":"Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis","volume":"27","author":"Sand","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.soncn.2022.151284_bib0017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","article-title":"Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.soncn.2022.151284_bib0018","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","article-title":"Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.soncn.2022.151284_bib0019","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00345-020-03510-7","article-title":"Penile cancer: potential target for immunotherapy?","volume":"39","author":"Vanthoor","year":"2021","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.soncn.2022.151284_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.soncn.2022.151284_bib0021","first-page":"481","article-title":"Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies","volume":"66","author":"Spiess","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soncn.2022.151284_bib0022","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"9769","key":"10.1016\/j.soncn.2022.151284_bib0023","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soncn.2022.151284_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11255-019-02302-2","article-title":"HPV infection in urology practice","volume":"52","author":"Sarier","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.soncn.2022.151284_bib0025","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.soncn.2022.151284_bib0026","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/v9080229","article-title":"Targeting persistent human papillomavirus infection","volume":"9","author":"Shanmugasundaram","year":"2017","journal-title":"Viruses"},{"issue":"7875","key":"10.1016\/j.soncn.2022.151284_bib0027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.soncn.2022.151284_bib0028","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jech-2020-216305","article-title":"Cost-effectiveness of extending the HPV vaccination to boys: a systematic review","volume":"75","author":"Linertova","year":"2021","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.soncn.2022.151284_bib0029","unstructured":"The American College of Obstetricians and Gynecologists (ACOG). Human papillomavirus vaccination. Available at: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2020\/08\/human-papillomavirus-vaccination. Accessed May 2, 2022."},{"issue":"49","key":"10.1016\/j.soncn.2022.151284_bib0030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination \u2014 updated recommendations of the Advisory Committee on Immunization Practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.soncn.2022.151284_bib0031","series-title":"Mechanism of Carcinogenesis and Progression","first-page":"1","author":"Vos","year":"2021"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0032","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOU.0000000000000712","article-title":"Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy","volume":"30","author":"Thomas","year":"2020","journal-title":"Curr Opin Urol"},{"issue":"26","key":"10.1016\/j.soncn.2022.151284_bib0033","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2013.04.010","article-title":"HPV vaccination among adolescent males: results from the National Immunization Survey-Teen","volume":"31","author":"Reiter","year":"2013","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.soncn.2022.151284_bib0034","first-page":"1705","article-title":"Recommendations on the use of quadrivalenthuman papillomavirus vaccine in males\u2013Advisory Committee on Immunization Practices (ACIP)","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.soncn.2022.151284_bib0035","unstructured":"White S. Action Area 1: HPV prevention via gender neutral vaccination programmes. Available at: https:\/\/www.europeancancer.org\/2-standard\/107-hpv-action-area-1-hpv-prevention-via-gender-neutral-vaccination-programmes. Accessed May 2, 2022."},{"issue":"19","key":"10.1016\/j.soncn.2022.151284_bib0036","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"41","key":"10.1016\/j.soncn.2022.151284_bib0037","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Eurosurveillance"},{"issue":"17","key":"10.1016\/j.soncn.2022.151284_bib0038","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.soncn.2022.151284_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1756287212465456","article-title":"Primary prevention and vaccination for penile cancer","volume":"5","author":"Shabbir","year":"2013","journal-title":"Ther Adv Urol"},{"issue":"19","key":"10.1016\/j.soncn.2022.151284_bib0040","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2018.03.024","article-title":"Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination","volume":"36","author":"Ng","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.soncn.2022.151284_bib0041","doi-asserted-by":"crossref","first-page":"k3837","DOI":"10.1136\/bmj.k3837","article-title":"Gender neutral vaccination against HPV","volume":"362","author":"Powell","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.soncn.2022.151284_bib0042","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.bjc.6604023","article-title":"The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting","volume":"97","author":"Kim","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.soncn.2022.151284_bib0043","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/ijpvm.IJPVM_49_17","article-title":"Human papillomavirus vaccination uptake in Canada: a systematic review and meta-analysis","volume":"8","author":"Bird","year":"2017","journal-title":"Int J Prev Med"},{"issue":"3","key":"10.1016\/j.soncn.2022.151284_bib0044","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10900-016-0284-5","article-title":"Variation in human papillomavirus vaccine uptake and acceptability between female and male adolescents and their caregivers","volume":"42","author":"Johnson","year":"2017","journal-title":"J Community Health"},{"issue":"2","key":"10.1016\/j.soncn.2022.151284_bib0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0017896915572705","article-title":"Beliefs and knowledge about the human papillomavirus vaccine among undergraduate men","volume":"75","author":"Hunter","year":"2015","journal-title":"Health Educ J"},{"issue":"6","key":"10.1016\/j.soncn.2022.151284_bib0046","article-title":"HPV vaccine and college-age men: a scoping review","volume":"4","author":"Laseron","year":"2020","journal-title":"Am J Men's Health"},{"key":"10.1016\/j.soncn.2022.151284_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106168","article-title":"Impact of school-based educational interventions in middle adolescent populations (15-17yrs) on human papillomavirus (HPV) vaccination uptake and perceptions\/knowledge of HPV and its associated cancers: A systematic review","volume":"139","author":"Flood","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.soncn.2022.151284_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.soncn.2022.151284_bib49","doi-asserted-by":"crossref","unstructured":"Giuliano AR, Anic G, Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol. 2010;117(2 Suppl):S15-S19. https:\/\/doi.org\/10.1016\/j.ygyno.2010.01.026","DOI":"10.1016\/j.ygyno.2010.01.026"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208122000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208122000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:37:05Z","timestamp":1760081825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208122000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0749208122000377"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2022.151284","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2022.151284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151284"}}